10/17/2025 | Companies

accessible medicine, anxiety, Apixaban, art therapy, blood pressure management, BPV advocacy, cardiovascular disease, clinical trials, Cystadrops, depression, dermatology, diabetes, digital health, digital therapeutics, disease management, Dymista, Elidel, global collaboration, global health, global initiatives, government partnerships, HCP training, health apps, healthcare access, healthcare technology, hypertension, hypertension awareness, immersive VR therapy, innovative therapies, medication adherence, mental health, mental health awareness, multiple sclerosis, NCDs, noncommunicable diseases, ophthalmology, patient education, patient outcomes, patient support, pharmaceutical launches, pharmacovigilance, podcasts, PrGlatiramer Acetate, public health campaigns, Relpax, research, respiratory diseases, Rizmoic, RRMS, RYZUMVI, sotagliflozin, stigma reduction, stroke, Sugammadex, telemedicine, Viatris, Zeforus

10/10/2025 | Companies

aging population, antiretroviral therapy, cancer, cardiovascular disease, chronic disease comorbidities, chronic disease management, community health, COPD, cross-sector collaboration, cultural competence, diabetes, digital education platforms, digital health, disease awareness, disease management tools, generational health differences, global health, global healthcare, global partnerships, global patient support, health equity, health literacy, healthcare access, healthcare infrastructure, healthcare innovation, healthcare policy, healthcare professional education, healthcare system resilience, healthcare workforce, HIV treatment, influenza vaccination, integrated care, interdisciplinary platforms, international healthcare programs, lifelong care, medical conferences, medical training, multiple sclerosis, NCD Academy, NCD integration, non-communicable diseases, patient advocacy, patient education, patient empowerment, patient engagement, pharmaceutical access, primary care, shared decision-making, sustainable healthcare, vaccine preventable diseases, Viatris, WHO leading causes of death

02/19/2025 | Companies

career journey, COVID-19, employee appreciation, future generations, global health, Great Place to Work, high-quality medicines, leadership, Leo, mentorship, mergers, Netherlands, patient impact, personal motivation, pharmaceutical industry, professional legacy, strategic projects, supply chain, team collaboration, Viatris, workplace inclusivity

10/29/2024 | Companies

2020 baseline, climate change, climate risk assessment, climate scenario analysis, emissions reduction targets, environmental resilience, GHG emissions, greenhouse gas reduction, Ireland, Little Island facility, operational continuity, operational efficiency, Paris Agreement, renewable electricity contract, renewable energy, SBTi, scope 1 emissions, scope 2 emissions, scope 3 emissions, sustainability, Viatris, water resources

10/14/2024 | Companies

2023 initiatives, ARV bottle packs, Cairo facility, carton-less initiatives, e-labeling, high-quality medicines, multilingual packaging, oral-solid dose, packaging reduction, paper reduction, PCTFE directive, PCTFE mitigation, plastic optimization, polythene bags, QR codes, quadrilingual packs, regulatory compliance, shared pack initiative, shipping boxes, shrink bundle film, standardization, supply chain flexibility, sustainable practices, trilingual packs, Viatris, waste reduction, wood reduction

10/26/2023 | Companies

AMR Industry Alliance, Antibiotic Manufacturing Standard, Carbon Emission Reduction, CEO Water Mandate, Heat Pump Technology, Landfill Reduction, Sludge Dryer, Supplier Risk Assessments, UN Global Compact, Viatris, Waste Reduction, Waste-to-Energy Facilities, Water Conservation, Water Management, Water Risk Assessments, World Resource Institute

02/16/2023 | Companies

critical medicines, Direct Relief, medical, Russia, Ukraine, Viatris, War